Bionano Genomics, Inc. — Director's Dealing 2018

Aug 21, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-21

Reporting Person: Luderer Albert (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$42.80	2021-10-13	Common Stock (140)		Direct
Stock Option (right to buy)	$64.20	2025-01-28	Common Stock (280)		Direct
Stock Option (right to buy)	$1.28	2027-11-06	Common Stock (8761)		Direct

Footnotes

F1: The shares subject to the option are fully vested and exercisable.

F2: 25% of the shares vested on January 29, 2016, and the remaining shares vest in 12 equal quarterly installments thereafter.

F3: 25% of the shares vested on February 7,2017, and the remaining shares vest in 12 equal quarterly installments thereafter.